Key Approvals by Shareholders

1. Regularization of Mr. Swanith Kapoor as Non-Executive Independent Director

  • Reason for Change: Regularization of appointment
  • Director Identification Number (DIN): 11662482
  • Effective Date: June 2, 2026
  • Term: 5 consecutive years (from June 2, 2026 to June 1, 2031)
  • Profile: Mr. Kapoor is a qualified legal professional holding B.B.A. LL.B. (Hons.) with specialization in Corporate Law from the School of Law, University of Petroleum and Energy Studies, Dehradun, Uttrakhand (awarded University Silver Medal). He has completed a Post Graduate Diploma in Medical Law and Ethics from NLSIU, Bengaluru, and is currently pursuing a Master's in Business Laws from NLSIU, Bengaluru. Work experience includes Legal Intern with TCS, Mumbai and Dhir & Dhir Law Offices, New Delhi.
  • Relationships: Not related to any other director of the company
  • Regulatory Status: Not debarred from holding director office by virtue of any SEBI order or authority

2. Reappointment of Mr. Aditya Arora as Whole Time Director

  • Reason for Change: Reappointment
  • Director Identification Number (DIN): 07320410
  • Effective Date: September 30, 2026
  • Term: 5 years (from September 30, 2026 to September 29, 2031)
  • Office Status: Office liable to retire by rotation
  • Profile: Mr. Arora holds a Bachelor's degree in Commerce from Delhi University. He has been associated with the company's Board since October 2015. He oversees production, quality assurance, quality control functions across all manufacturing units, and regulatory filings. The company credits him with bringing youthful energy, new perspectives, and significant contributions toward making the company a leading manufacturer of finished pharmaceutical products.
  • Family Relationships:
  • Mr. Ajay Kumar Arora - Father
  • Mrs. Geeta Arora - Mother
  • Mr. Ramesh Kumar - Father's Brother
  • Mrs. Anju Arora - Father's Brother's Wife
  • Regulatory Status: Not debarred from holding director office by virtue of any SEBI order or authority

Additional Information

  • The disclosure was filed with BSE Limited on September 2, 2026
  • Signed by Gurpreet Kaur, Company Secretary & Compliance Officer
  • This intimation follows a previous intimation dated August 9, 2026

Financial Impact

Financial impact not quantified in the disclosure.